Method for rapidly judging pancreatin activation end point and pancreatin preparation method

By isopropanol treatment and precipitation of pancreatic plasma during trial enzyme activation, the solution is measured to quickly determine the end point of trial enzyme activation, which solves the problem of complex operation and inappropriateness in industrial production in the prior art. Simplified operation and improved production efficiency.

CN119082259APending Publication Date: 2024-12-06SICHUAN DEBOER PHARM CO LTD
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
CN202411271536.7
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-11
Publication Date
2024-12-06

AI Technical Summary

Technical Problem

The method for determining the degree of trypsin activation in the prior art is complicated to operate, has a long time, and is not suitable for the trypsin preparation process, and cannot be applied to industrial production alone.

Method used

By stirring the pancreatic slurry during the activation of trypsin, adding isopropanol, filtration and precipitation, the solution material-to-liquid ratio is determined to quickly determine the end point of trypsin activation. It is simple to operate and is suitable for industrial production.

Benefits of technology

It realizes rapid and accurate determination of the end point of trypsin activation, simplifies the operating process, is suitable for industrial production, and reduces the frequency of activation detection.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119082259A_ABST
    Figure CN119082259A_ABST
Patent Text Reader

Abstract

The invention discloses a method for rapidly judging a pancreatin activation end point and a pancreatin preparation method. The method comprises the following steps: (1) taking pancreatic pulp in a pancreatin activation process, and stirring; (2) adding isopropanol with the light weight ratio of 0.84, and stirring; (3) filtering to remove insoluble tissue fibers to obtain filtrate; (4) washing tissue fibers of the filtrate by using isopropanol with the light weight of 0.84; (5) adding isopropanol with the light ratio of 0.84 into the filtrate for precipitation to enable the light ratio of the mixed solution to be 0.87-0.88, and stirring; and (6) after standing, observing the material-liquid ratio of the solution, and if the material-liquid ratio is greater than 60%, judging that the activation end point is reached, namely the ratio of the liquid to the total volume of the solution. The pancreatin activation endpoint can be quickly identified by measuring the solid-liquid ratio of the solution after the pancreatin pulp in the pancreatin activation process is subjected to a series of treatment, and the method is simple to operate, short in time and suitable for the industrial production process.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of pancreatic enzyme preparation, in particular to a method for rapidly determining a pancreatic enzyme activation endpoint and a method for preparing pancreatic enzyme. Background Art

[0002] Pancreatin is a product extracted from animal pancreas. It is a digestive aid and mainly contains trypsin, amylase and lipase. Trypsin can convert protein into peptone, amylase can convert starch into dextrin and sugar, and lipase can break down fat into glycerol and fatty acids, thereby promoting digestion and increasing appetite.

[0003] The main active substances of pancreatic enzymes are trypsin, amylase and lipase, among which amylase and lipase exist in active forms, while trypsin mainly exists in the form of trypsinogen, which is inactive. Therefore, during the preparation process, it is usually necessary to use an activating enzyme to cut off the lysine at position 6 and isoleucine at position 7 of trypsinogen, and activate it to convert it into active trypsin to exert its effect. This activation can also be carried out through the self-catalytic reaction of trypsin.

[0004] The activation of trypsin is a step-by-step process. The activating enzyme will first activate part of the trypsinogen to form partially active trypsin. Subsequently, these partially active trypsin will further activate the trypsinogen until it becomes fully active trypsin. After full activation, the activity of trypsin gradually decreases. Therefore, in the preparation process, trypsin activity is used as an activation indicator.

[0005] In the process of industrial pancreatic enzyme preparation, due to the different pig feeding methods, pig ages, breeds and other conditions in different breeding farms, the differences in pig pancreases obtained are very large, and the use of a fixed activation process cannot fully meet production needs. If the zymogen is not fully activated, only unstable and low-activity pancreatic enzymes can be obtained, which will affect the precipitation process and prolong the process time. If over-activated, trypsin will self-hydrolyze and further degrade into protein fragments, and lose its activity. Therefore, it is necessary to establish a method to determine the degree of activation to control the optimal activation time.

[0006] At present, the conventional control method is to detect the trypsin content, such as application number: CN201210506087.0, a trypsin detection method, the steps are as follows: react trypsin with core-shell nanoparticles to obtain a reaction product; detect the absorbance value of the core-shell nanoparticles in the reaction product; detect the absorbance value of the metal nanoparticles in the reaction product; calculate the ratio of the absorbance value of the metal nanoparticles to the absorbance value of the core-shell nanoparticles, and obtain the trypsin content according to the standard curve. Application number: CN201810913939.5, a preparation method of ratio-type CNQDs / TiO2 / AuNCs composite fluorescent microspheres and its application; the specific steps are: first prepare CNQDs solution, CNQDs / TiO2 fluorescent microspheres and ratio-type CNQDs / TiO2 / AuNCs composite fluorescent microspheres; then use the ratio-type CNQDs / TiO2 / AuNCs composite fluorescent microspheres to detect trypsin, and the detection steps are: add the trypsin standard solution to the ratio-type CNQDs / TiO2 / AuNCs composite fluorescent microsphere aqueous solution, obtain fluorescence images and fluorescence spectrum curves at different concentrations, construct a trypsin detection visualization array and standard curve, and realize the visualization and quantitative detection of trypsin in the sample; the above method only considers the activity of trypsin, and cannot be applied to the trypsin preparation process alone, and its operation is complicated and time-consuming, and can only be applied to the experimental stage.

[0007] In view of this, this application is hereby filed. Summary of the invention

[0008] The problem with the prior art is that the method for determining the degree of pancreatic enzyme activation is mainly to detect the trypsin content, which is complicated to operate and is not suitable for the pancreatic enzyme preparation process. The present invention provides a method for quickly determining the end point of pancreatic enzyme activation and a method for preparing pancreatic enzyme. After a series of treatments are performed on the pancreatic pulp during the pancreatic enzyme activation process, the solid-liquid ratio of the solution is measured, so that the end point of pancreatic enzyme activation can be quickly identified. The operation is simple, the time is short, and it is suitable for industrial production processes.

[0009] The present invention is achieved through the following technical solutions:

[0010] In a first aspect, the present invention provides a method for rapidly determining the end point of pancreatic enzyme activation, comprising the following steps:

[0011] (1) taking pancreatic pulp during the pancreatic enzyme activation process and stirring it;

[0012] (2) adding isopropanol with a specific gravity of 0.84 and stirring;

[0013] (3) filtering to remove insoluble tissue fibers to obtain a filtrate;

[0014] (4) Wash the tissue fibers of the filtrate with isopropanol having a specific gravity of 0.84;

[0015] (5) adding isopropanol with a specific gravity of 0.84 to the filtrate to precipitate the mixed solution to a specific gravity of 0.87-0.88, and stirring;

[0016] (6) After standing, observe the solid-liquid ratio of the solution. If the solid-liquid ratio is greater than 60%, it is determined that the activation endpoint has been reached. The solid-liquid ratio is the ratio of the liquid volume to the total volume of the solution.

[0017] In a specific embodiment, a method for quickly determining the end point of pancreatic enzyme activation comprises the following steps:

[0018] (1) taking one portion of pancreatic pulp from the pancreatic enzyme activation process and stirring it;

[0019] (2) adding 0.25 parts of isopropanol with a specific gravity of 0.84 and stirring;

[0020] (3) filtering to remove insoluble tissue fibers to obtain a filtrate;

[0021] (4) Wash the tissue fibers of the filtrate with 0.25 parts of isopropanol with a specific gravity of 0.84;

[0022] (5) adding 3.3 parts of isopropanol with a specific gravity of 0.84 to the filtrate to precipitate the mixed solution to a specific gravity of 0.87-0.88, and stirring;

[0023] (6) After standing, measure the solid-liquid ratio of the solution. If the solid-liquid ratio is greater than 60%, it is determined that the activation endpoint has been reached.

[0024] The parts mentioned above are all parts by volume.

[0025] The specific measurement method of the material-liquid ratio is: measure the total material height and the clear liquid height respectively, material-liquid ratio = clear liquid height / total material height*100%.

[0026] In a specific embodiment, in step (5), the stirring time is 5 minutes.

[0027] In a specific embodiment, in step (6), the standing time is 5 minutes.

[0028] In a specific embodiment, in step (3), filtration is performed using a 60-80 mesh sieve.

[0029] In a specific embodiment, the isopropanol is isopropanol at 20-25°C.

[0030] In a specific embodiment, in step (2), the solution is stirred for 2 minutes.

[0031] In a specific embodiment, in step (1), stirring is performed using a magnetic stirrer.

[0032] In a second aspect, the present invention also provides a method for preparing pancreatic enzyme for rapidly determining the end point of pancreatic enzyme activation, comprising the following steps:

[0033] (1) Take one portion of pancreatic pulp at different time points during the pancreatic enzyme production and activation process;

[0034] (2) using the method for determining the activation endpoint of pancreatic enzymes for each portion of pancreatic pulp to detect whether the activation endpoint is reached at that time point;

[0035] (3) If it is detected that the activation endpoint is reached at a certain time point, the pancreatic enzyme activation is stopped.

[0036] In a specific embodiment, the interval time in step (1) is 1 to 2 hours. When step (3) detects that a certain node has reached the activation endpoint, in the subsequent pancreatic enzyme production and activation process, one portion of pancreatic pulp is taken every 10 to 20 minutes from one hour before the node time to detect whether the activation endpoint has been reached.

[0037] After determining the approximate time point when pancreatic enzyme activation terminates, the present invention can further narrow the detection range in the subsequent activation process and reduce the frequency of activation detection. Only a short time interval detection is required before the approximate time point, so that the activation endpoint can be quickly determined.

[0038] Compared with the prior art, the present invention has the following advantages and beneficial effects:

[0039] The embodiments of the present invention provide a method for quickly determining the end point of pancreatic enzyme activation and a method for preparing pancreatic enzyme. After a series of treatments are performed on the pancreatic pulp during the pancreatic enzyme activation process, the end point of pancreatic enzyme activation can be quickly identified by measuring the solid-liquid ratio of the solution. The operation is simple, the time is short, and it is suitable for industrial production processes. BRIEF DESCRIPTION OF THE DRAWINGS

[0040] In order to more clearly illustrate the technical solutions of the exemplary embodiments of the present invention, the drawings required for use in the embodiments will be briefly introduced below. It should be understood that the following drawings only show certain embodiments of the present invention and therefore should not be regarded as limiting the scope. For ordinary technicians in this field, other related drawings can be obtained based on these drawings without paying creative work.

[0041] Figure 1 A trend chart of the solid-liquid ratio and the enzyme activity value after standing for 5 minutes provided in an embodiment of the present invention;

[0042] Figure 2 A trend chart of the solid-liquid ratio and the enzyme activity value after standing for 10 minutes provided in an embodiment of the present invention;

[0043] Figure 3This is a trend chart of the solid-liquid ratio and the enzyme activity value after standing for 20 minutes provided in an embodiment of the present invention. DETAILED DESCRIPTION

[0044] In order to make the purpose, technical solutions and advantages of the present invention more clearly understood, the present invention is further described in detail below in conjunction with embodiments. The illustrative embodiments of the present invention and their description are only used to explain the present invention and are not intended to limit the present invention.

[0045] In the following description, a large number of specific details are set forth in order to provide a thorough understanding of the present invention. However, it is apparent to one of ordinary skill in the art that these specific details need not be employed to practice the present invention. In other embodiments, in order to avoid confusing the present invention, well-known materials or methods are not specifically described.

[0046] Throughout the specification, references to "one embodiment," "an embodiment," "an example," or "an example" mean that a particular feature, structure, or characteristic described in conjunction with the embodiment or example is included in at least one embodiment of the present invention. Therefore, the phrases "one embodiment," "an embodiment," "an example," or "an example" appearing in various places throughout the specification do not necessarily all refer to the same embodiment or example. In addition, particular features, structures, or characteristics may be combined in one or more embodiments or examples in any suitable combination and / or subcombination. The term "and / or" as used herein includes any and all combinations of one or more of the associated listed items.

[0047] The "range" disclosed in this application is defined in the form of a lower limit and an upper limit, and a given range is defined by selecting a lower limit and an upper limit, and the selected lower limit and upper limit define the boundaries of the particular range. The range defined in this way can be inclusive or exclusive of the end values, and can be arbitrarily combined, that is, any lower limit can be combined with any upper limit to form a range.

[0048] In the description of the present invention, unless otherwise specified, all embodiments and optional embodiments of the present application can be combined with each other to form a new technical solution.

[0049] In the description of the present invention, unless otherwise specified, all technical features and optional technical features of the present application can be combined with each other to form a new technical solution.

[0050] In the description of the present invention, unless otherwise specified, the words "include" and "comprising" mentioned in the present application may be open-ended or closed-ended. For example, the words "include" and "comprising" may mean that other components not listed may also be included or comprised, or may only include or comprise the listed components.

[0051] In a first aspect, the present invention provides a method for rapidly determining the end point of pancreatic enzyme activation, comprising the following steps:

[0052] (1) taking pancreatic pulp during the pancreatic enzyme activation process and stirring it;

[0053] (2) adding isopropanol with a specific gravity of 0.84 and stirring;

[0054] (3) filtering to remove insoluble tissue fibers to obtain a filtrate;

[0055] (4) Wash the tissue fibers of the filtrate with isopropanol having a specific gravity of 0.84;

[0056] (5) adding isopropanol with a specific gravity of 0.84 to the filtrate to precipitate the mixed solution to a specific gravity of 0.87-0.88, and stirring;

[0057] (6) After standing, observe the solid-liquid ratio of the solution. If the solid-liquid ratio is greater than 60%, it is determined that the activation endpoint has been reached.

[0058] In a specific embodiment, a method for quickly determining the end point of pancreatic enzyme activation comprises the following steps:

[0059] (1) taking one portion of pancreatic pulp from the pancreatic enzyme activation process and stirring it;

[0060] (2) adding 0.25 parts of isopropanol with a specific gravity of 0.84 and stirring;

[0061] (3) filtering to remove insoluble tissue fibers to obtain a filtrate;

[0062] (4) Wash the tissue fibers of the filtrate with 0.25 parts of isopropanol with a specific gravity of 0.84;

[0063] (5) adding 3.3 parts of isopropanol with a specific gravity of 0.84 to the filtrate to precipitate the mixed solution to a specific gravity of 0.87-0.88, and stirring;

[0064] (6) After standing, observe the solid-liquid ratio of the solution. If the solid-liquid ratio is greater than 60%, it is determined that the activation endpoint has been reached.

[0065] In a specific embodiment, in step (5), the stirring time is 5 minutes.

[0066] In a specific embodiment, in step (6), the standing time is 5 minutes.

[0067] In a specific embodiment, in step (3), filtration is performed using a 60-80 mesh sieve.

[0068] In a specific embodiment, the isopropanol is isopropanol at 20-25°C.

[0069] In a specific embodiment, in step (2), the solution is stirred for 2 minutes.

[0070] In a specific embodiment, in step (1), stirring is performed using a magnetic stirrer.

[0071] In a second aspect, the present invention also provides a method for preparing pancreatic enzyme for rapidly determining the end point of pancreatic enzyme activation, comprising the following steps:

[0072] (1) Take one portion of pancreatic pulp at different time points during the pancreatic enzyme production and activation process;

[0073] (2) using the method described above to detect whether the activation endpoint is reached at the time point for each pancreatic pulp;

[0074] (3) If it is detected that the activation endpoint is reached at a certain time point, the pancreatic enzyme activation is stopped.

[0075] In a specific embodiment, the interval time in step (1) is 1 to 2 hours. When step (3) detects that a certain node has reached the activation endpoint, in the subsequent pancreatic enzyme production and activation process, one portion of pancreatic pulp is taken every 10 to 20 minutes from one hour before the node time to detect whether the activation endpoint has been reached.

[0076] After determining the approximate time point when pancreatic enzyme activation terminates, the present invention can further narrow the detection range in the subsequent activation process and reduce the frequency of activation detection. Only a short time interval detection is required before the approximate time point, so that the activation endpoint can be quickly determined.

[0077] Example 1

[0078] The present invention provides a method for rapidly determining the end point of pancreatic enzyme activation, comprising the following steps:

[0079] (1) Take one portion of pancreatic pulp from 2 h of pancreatic enzyme activation and stir it on a magnetic stirrer;

[0080] (2) Add 0.25 parts of isopropanol with a specific gravity of 0.84 / 20-25°C to terminate the reaction and stir for 2 minutes;

[0081] (3) filtering through a 60-80 mesh sieve to remove insoluble tissue fibers to obtain a filtrate;

[0082] (4) Wash the tissue fibers of the filtrate with 0.25 parts of isopropanol having a specific gravity of 0.84 / 20-25°C;

[0083] (5) Slowly adding 3.3 parts of isopropanol with a specific gravity of 0.84 / 20-25°C to the filtrate with stirring to precipitate the mixed solution to a specific gravity of 0.87-0.88, and stirring for 5 minutes;

[0084] (6) After standing for 5 min, 10 min, and 20 min, the solid-liquid ratio of the solution was observed and the enzyme activity was tested.

[0085] Example 2

[0086] The present invention provides a method for rapidly determining the end point of pancreatic enzyme activation, comprising the following steps:

[0087] (1) Take one portion of pancreatic pulp from 3 hours after pancreatic enzyme activation and stir it on a magnetic stirrer;

[0088] (2) Add 0.25 parts of isopropanol with a specific gravity of 0.84 / 20-25°C to terminate the reaction and stir for 2 minutes;

[0089] (3) filtering through a 60-80 mesh sieve to remove insoluble tissue fibers to obtain a filtrate;

[0090] (4) Wash the tissue fibers of the filtrate with 0.25 parts of isopropanol having a specific gravity of 0.84 / 20-25°C;

[0091] (5) Slowly adding 3.3 parts of isopropanol with a specific gravity of 0.84 / 20-25°C to the filtrate with stirring to precipitate the mixed solution to a specific gravity of 0.87-0.88, and stirring for 5 minutes;

[0092] (6) After standing for 5 min, 10 min, and 20 min, the solid-liquid ratio of the solution was observed and the enzyme activity was tested.

[0093] Example 3

[0094] The present invention provides a method for rapidly determining the end point of pancreatic enzyme activation, comprising the following steps:

[0095] (1) Take one portion of pancreatic pulp 4 hours after the pancreatic enzyme activation process and stir it on a magnetic stirrer;

[0096] (2) Add 0.25 parts of isopropanol with a specific gravity of 0.84 / 20-25°C to terminate the reaction and stir for 2 minutes;

[0097] (3) filtering through a 60-80 mesh sieve to remove insoluble tissue fibers to obtain a filtrate;

[0098] (4) Wash the tissue fibers of the filtrate with 0.25 parts of isopropanol having a specific gravity of 0.84 / 20-25°C;

[0099] (5) Slowly adding 3.3 parts of isopropanol with a specific gravity of 0.84 / 20-25°C to the filtrate with stirring to precipitate the mixed solution to a specific gravity of 0.87-0.88, and stirring for 5 minutes;

[0100] (6) After standing for 5 min, 10 min, and 20 min, the solid-liquid ratio of the solution was observed and the enzyme activity was tested.

[0101] Example 4

[0102] The present invention provides a method for rapidly determining the end point of pancreatic enzyme activation, comprising the following steps:

[0103] (1) Take one portion of pancreatic pulp from the 6-hour pancreatic enzyme activation process and stir it on a magnetic stirrer;

[0104] (2) Add 0.25 parts of isopropanol with a specific gravity of 0.84 / 20-25°C to terminate the reaction and stir for 2 minutes;

[0105] (3) filtering through a 60-80 mesh sieve to remove insoluble tissue fibers to obtain a filtrate;

[0106] (4) Wash the tissue fibers of the filtrate with 0.25 parts of isopropanol having a specific gravity of 0.84 / 20-25°C;

[0107] (5) Slowly adding 3.3 parts of isopropanol with a specific gravity of 0.84 / 20-25°C to the filtrate with stirring to precipitate the mixed solution to a specific gravity of 0.87-0.88, and stirring for 5 minutes;

[0108] (6) After standing for 5 min, 10 min, and 20 min, the solid-liquid ratio of the solution was observed and the enzyme activity was tested.

[0109] Example 5

[0110] The present invention provides a method for rapidly determining the end point of pancreatic enzyme activation, comprising the following steps:

[0111] (1) Take one portion of pancreatic pulp from 8 hours of pancreatic enzyme activation and stir it on a magnetic stirrer;

[0112] (2) Add 0.25 parts of isopropanol with a specific gravity of 0.84 / 20-25°C to terminate the reaction and stir for 2 minutes;

[0113] (3) filtering through a 60-80 mesh sieve to remove insoluble tissue fibers to obtain a filtrate;

[0114] (4) Wash the tissue fibers of the filtrate with 0.25 parts of isopropanol having a specific gravity of 0.84 / 20-25°C;

[0115] (5) Slowly adding 3.3 parts of isopropanol with a specific gravity of 0.84 / 20-25°C to the filtrate with stirring to precipitate the mixed solution to a specific gravity of 0.87-0.88, and stirring for 5 minutes;

[0116] (6) After standing for 5 min, 10 min, and 20 min, the solid-liquid ratio of the solution was observed and the enzyme activity was tested.

[0117] The enzyme activity test was performed on the treated solutions of Examples 1-5, and the results are shown in Table 1.

[0118] Table 1

[0119]

[0120] As can be seen from Table 1, after standing for 5 minutes, when the material-liquid ratio reached 60%, the trypsin activity value reached the highest range, indicating that the trypsin was basically activated after 6 hours, and the enzyme activity value at 8 hours was almost the same as that at 6 hours. Therefore, it can be determined that the activation process can be terminated at 6 hours.

[0121] When the solution was left to stand for 10 minutes and 20 minutes respectively, it was found that the time for the solid-liquid ratio to reach 60% was earlier, and the enzyme activity value was relatively low, and did not reach the optimal activation value. Figure 1-3 As shown, when the standing time is too long, the trend of the solid-liquid ratio and the enzyme activity value becomes weak, and the activation endpoint cannot be accurately determined by the solid-liquid ratio. Therefore, the present invention selects the mixed solution to stand for 5 minutes, and the activation endpoint can be quickly and accurately determined by the solid-liquid ratio being greater than 60%.

[0122] The specific implementation methods described above further illustrate the objectives, technical solutions and beneficial effects of the present invention in detail. It should be understood that the above description is only a specific implementation method of the present invention and is not intended to limit the scope of protection of the present invention. Any modifications, equivalent substitutions, improvements, etc. made within the spirit and principles of the present invention should be included in the scope of protection of the present invention.

Claims

1. A method for rapidly determining the end point of pancreatic enzyme activation, characterized in that: The steps include: (1) taking pancreatic pulp during the pancreatic enzyme activation process and stirring it; (2) adding isopropanol with a specific gravity of 0.84 and stirring; (3) filtering to remove insoluble tissue fibers to obtain a filtrate; (4) Wash the tissue fibers of the filtrate with isopropanol having a specific gravity of 0.84; (5) adding isopropanol with a specific gravity of 0.84 to the filtrate to precipitate the mixed solution to a specific gravity of 0.87-0.88, and stirring; (6) After standing, observe the solid-liquid ratio of the solution. If the solid-liquid ratio is greater than 60%, it is determined that the activation endpoint has been reached. The solid-liquid ratio is the ratio of the liquid volume to the total volume of the solution.

2. A method for rapidly determining the end point of pancreatic enzyme activation according to claim 1, characterized in that: The specific steps are as follows: (1) taking one portion of pancreatic pulp from the pancreatic enzyme activation process and stirring it; (2) adding 0.25 parts of isopropanol with a specific gravity of 0.84 and stirring; (3) filtering to remove insoluble tissue fibers to obtain a filtrate; (4) Wash the tissue fibers of the filtrate with 0.25 parts of isopropanol with a specific gravity of 0.84; (5) adding 3.3 parts of isopropanol with a specific gravity of 0.84 to the filtrate to precipitate the mixed solution to a specific gravity of 0.87-0.88, and stirring; (6) After standing, observe the solid-liquid ratio of the solution. If the solid-liquid ratio is greater than 60%, it is determined that the activation endpoint has been reached.

3. A method for rapidly determining the end point of pancreatic enzyme activation according to claim 2, characterized in that: In step (5), the stirring time is 5 min.

4. A method for rapidly determining the end point of pancreatic enzyme activation according to claim 2, characterized in that: In step (6), the standing time is 5 min.

5. The method for rapidly determining the end point of pancreatic enzyme activation according to claim 2, characterized in that: In step (3), filtering is performed using a 60-80 mesh sieve.

6. A method for rapidly determining the end point of pancreatic enzyme activation according to claim 2, characterized in that: The isopropanol is 20-25°C isopropanol.

7. A method for rapidly determining the end point of pancreatic enzyme activation according to claim 2, characterized in that: In step (2), the solution was stirred for 2 min.

8. The method for rapidly determining the end point of pancreatic enzyme activation according to claim 1, characterized in that: In step (1), stirring is performed using a magnetic stirrer.

9. A method for preparing pancreatic enzyme for rapidly determining the end point of pancreatic enzyme activation, characterized in that: The steps include: (1) Take one portion of pancreatic pulp at different time points during the pancreatic enzyme production and activation process; (2) using the method described in any one of claims 1 to 8 to detect whether the activation endpoint is reached at the time point for each pancreatic pulp; (3) If it is detected that the activation endpoint is reached at a certain time point, the pancreatic enzyme activation is stopped.

10. A method for preparing pancreatic enzyme for rapidly determining the end point of pancreatic enzyme activation according to claim 9, characterized in that: The interval time in step (1) is 1 to 2 hours. When step (3) detects that a certain node has reached the activation endpoint, in the subsequent pancreatic enzyme production and activation process, one portion of pancreatic pulp is taken every 10 to 20 minutes, one hour before the node time, to detect whether the activation endpoint has been reached.

Citation Information

Patent Citations

  • Method for detecting trypsin

    CN102944558A

  • Preparation method and application of ratio-type CNQDs / TiO2 / AuNCs composite fluorescent microsphere

    CN109115740A